Ignite Creation Date:
2025-12-25 @ 1:15 AM
Ignite Modification Date:
2026-02-27 @ 11:58 PM
Study NCT ID:
NCT04427293
Status:
RECRUITING
Last Update Posted:
2025-12-16
First Post:
2020-06-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC)
Sponsor:
Organization: